The prevalence of genital Chlamydia trachomatis in Australia 1997 - 2004: a systematic review

Vajdic, Claire M.; Middleton, Michael; Bowden, Francis J.; Fairley, Christopher K; Kaldor, John

doi:10.1071/sh05018

Cited by 61 publications

(68 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The sample size was calculated with reference to the World Health Organization guidelines for STI prevalence surveys (WHO, 2007). The prevalence of Chlamydia trachomatis is estimated to be approximately 5 % in the population of women attending sexual health clinics in Australia (Vajdic et al, 2005). A sample size of 203 women would be required to measure the prevalence of C. trachomatis within ±3.0 % using a 95 % confidence interval (CI) calculation.…”

Section: Methodsmentioning

confidence: 99%

The prevalence of urogenital micro-organisms detected by a multiplex PCR–reverse line blot assay in women attending three sexual health clinics in Sydney, Australia

McKechnie

Hillman

Jones

et al. 2011

Journal of Medical Microbiology

View full text Add to dashboard Cite

This study used a previously described multiplex PCR-based reverse line blot (mPCR/RLB) assay to assess the prevalence and distribution of 14 urogenital pathogens or putative pathogens, namely Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Trichomonas vaginalis, Gardnerella vaginalis, Ureaplasma parvum, Ureaplasma urealyticum, Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae, herpes simplex virus types 1 and 2, and human adenovirus. First-voided urine specimens and endocervical and self-collected vaginal swabs from each of 216 women attending three sexual health clinics in Sydney, Australia, were tested and the results were compared with those of reference methods for each organism. One hundred and sixty-eight women (77.7 %) had at least one and 105 (48.6 %) had more than one target organism, most commonly G. vaginalis and Ureaplasma spp. The prevalence of each of the four known sexually transmissible pathogens was ,5 %. Of the 216 women, 111 (51.4 %) reported at least one symptom consistent with genital or urethral infection, including discharge, pain or discomfort. Only G. vaginalis was detected more frequently in women with symptoms (P50.05). The specificity of the mPCR/RLB assay compared with that of the reference methods for each organism and for all specimen types was 100 %. The mean sensitivities of the mPCR/RLB assay compared with those of the reference methods for self-collected vaginal swabs, cervical swabs and first-voided urine specimens for all organisms were 99.3, 98.1 and 84.6 %, respectively; however, these differences were not significant. There were no differences in sensitivities between specimen types for C. trachomatis, N. gonorrhoeae, T. vaginalis and H. influenzae, although all were found infrequently. Overall, the mPCR/RLB platform was found to be an accurate testing platform in a sexual health clinic setting.

show abstract

Section: Methodsmentioning

confidence: 99%

The prevalence of urogenital micro-organisms detected by a multiplex PCR–reverse line blot assay in women attending three sexual health clinics in Sydney, Australia

McKechnie

Hillman

Jones

et al. 2011

Journal of Medical Microbiology

View full text Add to dashboard Cite

show abstract

“…La infección en las dos ciudades colombianas difiere de lo reportado en una revisión sistemática de Australia, en la cual fue de 3,3% (IC 95% = 2,8-3,9) en trabajadoras sexuales y 1,6% (IC 95% = 1,2-2,0) en hombres que tienen sexo con otros hombres 12 . Al mismo tiempo, resulta mayor que el reporte del grupo de Newman en 2012 quien halló una frecuencia del 4,2% (IC 95 = 3,7-4,7) en mujeres entre 15 y 49 años 9 .…”

Section: Discussionunclassified

“…En Australia, con base en una revisión sistemática de 40 estudios que agruparon 40.587 individuos, la prevalencia global de infección genital fue 4,6% (IC 95% = 4,4-4,8), siendo levemente mayor en las mujeres; 3,3% (IC 95% = 3,0-3,7) en mujeres atendidas en clínicas de salud sexual y 5,6% (IC 95% = 4,9-6,4%) en jóvenes y adolescentes 12 .…”

Section: Artículo Originalunclassified

“…Esto coincide con revisiones sistemáticas que han reportado infección en 12,3% (IC 95% = 10,6-14,2) de las mujeres con rango entre 0 y 32,7%; mientras que hombres 10,9% (IC 95% = 7,6-15,4%) con rango entre 0 y 23,3% 8 . Aunque varía con respecto a los resultados de una revisión sistemática en Australia, en la cual no se documentaron diferencias significativas según el sexo, así, en hombres indígenas fue 7,5% (IC 95% = 6,4-8,6%), en mujeres indígenas 8,7% (IC 95% = 7,9-9,7%), en hombres no indígenas 1,5% (IC 95% = 1,1-1,9) y en mujeres no indígenas 1,4% (IC 95% = 0,9-2,0%) 12 .…”

Section: Infecciones De Transmisión Sexualunclassified

See 1 more Smart Citation

Infección por Chlamydia trachomatis en pacientes de una institución de salud de Bogotá y Medellín, 2012-2015

Cardona‐Arias

Gallego-Atehortúa²,

Ríos-Osório

2016

Rev. chil. infectol.

View full text Add to dashboard Cite

“…14,15 The prevalence of chlamydia is~4.6% in heterosexuals under 29 years old in Australia. 16 If ETS had not been introduced, some of these individuals may not have been seen, due to clinic capacity, and this would constitute a missed opportunity to screen. Some would have been referred to return to our clinic or to their own general practitioner (GP).…”

Section: Discussionmentioning

confidence: 99%

An evaluation of an express testing service for sexually transmissible infections in low-risk clients without complications

Gamagedara¹,

Dobinson²,

Cummings³

et al. 2014

Sex. Health

Self Cite

View full text Add to dashboard Cite

Abstract. Background: One effective way of reducing the prevalence of sexually transmissible infections (STIs) in a population is ensuring easy access to clinical services and screening of populations at high risk of STIs, including HIV. We aimed to describe the features of clients using the express testing service (ETS) and the overall impact on the service. Methods: This retrospective cross-sectional study involved all clients attending the walk-in triage service at Melbourne Sexual Health Centre before the introduction of ETS in 2009 and after ETS (2011 and2012). Results: There were 32 720 and 82 265 consultations before and after ETS respectively. The ETS saw 4387 (9%) of 55 648 consultations (excluding appointments and results), giving rise to a fall in the proportion of lower-risk clients having full consultations (from 53% to 50% of consultations; P < 0.001). The consultations testing for HIV and chlamydia (Chlamydia trachomatis) were marginally higher (HIV: 48% v. 47%, P = 0.017; chlamydia: 70% v. 68%, P = 0.015) with ETS. Young (26 v. 27 years) females (38% v. 34%) utilised the ETS more (P < 0.001). The time taken for consultation and the total time spent in the clinic was significantly decreased during the ETS period (from 25 min to 6 min for consultation time and from 59 min to 29 min for total clinic time; P < 0.001). Conclusions: The data suggest that fast-track services such as ETS are effective in increasing access for higher-risk individuals while streamlining screening of asymptomatic low-risk clients.

show abstract

The prevalence of genital Chlamydia trachomatis in Australia 1997 - 2004: a systematic review

Abstract: The prevalence of genital chlamydial infection in Indigenous Australians and young adults is unacceptably high and quality epidemiological studies are urgently required to supplement the routinely collected national notification data.

Cited by 61 publications

References 40 publications

The prevalence of urogenital micro-organisms detected by a multiplex PCR–reverse line blot assay in women attending three sexual health clinics in Sydney, Australia

The prevalence of urogenital micro-organisms detected by a multiplex PCR–reverse line blot assay in women attending three sexual health clinics in Sydney, Australia

Infección por Chlamydia trachomatis en pacientes de una institución de salud de Bogotá y Medellín, 2012-2015

An evaluation of an express testing service for sexually transmissible infections in low-risk clients without complications

Contact Info

Product

Resources

About